Evofem Biosciences (NASDAQ:EVFM) Share Price Crosses Below 200 Day Moving Average – What’s Next?

Shares of Evofem Biosciences, Inc. (NASDAQ:EVFM) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.0075. Evofem Biosciences shares last traded at $0.0082, with a volume of 278,264 shares trading hands.

Evofem Biosciences Stock Down 5.7%

The company’s 50 day moving average price is $0.01 and its two-hundred day moving average price is $0.01. The firm has a market cap of $1.09 million, a PE ratio of -0.01 and a beta of -1.25.

Evofem Biosciences Company Profile

Evofem Biosciences is a clinical‐stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.

The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.